Contrasting the Performance of a Surgeon-Fashioned Extracellular Matrix Cylindrical Tricuspid Valve Versus a Mechanical Valve
- PMID: 40790959
- DOI: 10.1177/21501351251360694
Contrasting the Performance of a Surgeon-Fashioned Extracellular Matrix Cylindrical Tricuspid Valve Versus a Mechanical Valve
Abstract
We present a patient who as an infant required mitral and tricuspid valve replacement, with a mechanical valve used in the mitral position and a surgeon fashioned extracellular matrix of porcine small intestinal submucosa (SIS-ECM) (CorMatrix) valve in the tricuspid position. Five years later, the mechanical valve required replacement with a larger mechanical valve. Although the CorMatrix tricuspid valve did not show significant signs of thrombosis or calcification, it was also replaced with a mechanical valve. That mechanical valve thrombosed twice within one year and both times required surgery for replacement. After the second thrombotic event, however, a new hand sutured SIS-ECM valve was used in place of a mechanical valve. The new SIS-ECM tricuspid valve continues to function appropriately 17 months later, and the patient has remained asymptomatic.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: David L. S. Morales is a consultant for Abbott, Inc., Azyio, Inc., Berlin Heart, Inc., CorMatrix, Inc., Peca, Inc., Syncardia, Inc., and Xeltis, Inc., and a principal investigator for FDA trials sponsored by Peca, Inc. and Xeltis, Inc. Garick Hill is a consultant for Ultragenyx.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
